We are live on !
Find out more
Wilmington Funds Management Portfolio holdings
AUM
$988M
Turnover
26.35%
1-Year Est. Return
26.05%
This Fund
S&P 500
This Quarter Est. Return
+4.48%
1 Year Est. Return
+26.05%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$988M
AUM Growth
+$67.7M
(+7.4%)
Cap. Flow
+$35.7M
Cap. Flow % of AUM
Cap. Flow %
3.61%
Top 10 Holdings %
Top 10 Hldgs %
10.81%
Holding
873
New
103
Increased
253
Reduced
220
Closed
127
Avg Time Held
0.8
years
Top 10 Avg Time Held
0.5
years
Top 20 Avg Time Held
0.5
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AstraZeneca
AZN
|
+$6.38M |
| 2 |
AGN
Allergan Inc
AGN
|
+$5.74M |
| 3 |
Oceaneering
OII
|
+$4.45M |
| 4 |
FRX
FOREST LABORATORIES INC
FRX
|
+$3.94M |
| 5 |
TWC
TIME WARNER CABLE INC NEW COM STK
TWC
|
+$3.61M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CTXS
Citrix Systems Inc
CTXS
|
+$5.03M |
| 2 |
ExxonMobil
XOM
|
+$4.42M |
| 3 |
GE Aerospace
GE
|
+$3.28M |
| 4 |
Chevron
CVX
|
+$2.84M |
| 5 |
Herbalife
HLF
|
+$2.82M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 15.76% |
| 2 | Healthcare | 12.75% |
| 3 | Consumer Discretionary | 12.33% |
| 4 | Technology | 11.81% |
| 5 | Real Estate | 10.46% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1
Apple
AAPL
$5.02T
| $16.9M | 1.71% |
726,320
+94,780
| +15% | +$2.02M |
2013 Q2
4 quarters
|
|
2
DELISTED
Paramount Global Class B
PARA
| $11.9M | 1.2% |
191,230
+14,820
| +8% | +$882K |
2013 Q2
4 quarters
|
|
3
BorgWarner
BWA
$11.4B
| $11.2M | 1.13% |
195,142
+27,514
| +16% | +$1.51M |
2013 Q2
4 quarters
|
|
|
GMCR
4
DELISTED
KEURIG GREEN MTN INC
GMCR
| $10.6M | 1.07% |
84,840
+5,655
| +7% | +$617K |
2013 Q2
4 quarters
|
|
5
Simon Property Group
SPG
$68.3B
| $10.3M | 1.05% |
62,182
+228
| +0.4% | +$37.2K |
2013 Q2
4 quarters
|
|
6
Alphabet (Google) Class C
GOOG
$3.94T
| $9.8M | 1% |
340,332
+86,263
| +34% | +$2.34M |
2013 Q2
4 quarters
|
|
|
WLL
7
DELISTED
Whiting Petroleum Corporation
WLL
| $9.8M | 0.99% |
407
+46
| +13% | +$1.02M |
2013 Q2
4 quarters
|
|
8
CBRE Group
CBRE
$35.6B
| $9.17M | 0.93% |
286,210
+28,425
| +11% | +$821K |
2013 Q2
4 quarters
|
|
9
IPG Photonics
IPGP
$3.21B
| $8.66M | 0.88% |
125,810
+16,175
| +15% | +$1.09M |
2013 Q2
4 quarters
|
|
10
Perrigo
PRGO
$2.21B
| $8.46M | 0.86% |
58,060
+6,351
| +12% | +$900K |
2013 Q2
4 quarters
|
|
11
DELISTED
Ansys
ANSS
| $8.41M | 0.85% |
110,862
+13,488
| +14% | +$1.01M |
2013 Q2
4 quarters
|
|
12
Rockwell Automation
ROK
$49.3B
| $8.26M | 0.84% |
65,970
+9,800
| +17% | +$1.21M |
2013 Q2
4 quarters
|
|
|
GRA
13
DELISTED
W.R. Grace & Co.
GRA
| $8.24M | 0.83% |
87,200
+10,935
| +14% | +$1.03M |
2013 Q2
4 quarters
|
|
14
Regeneron Pharmaceuticals
REGN
$83.7B
| $8.23M | 0.83% |
29,150
+4,430
| +18% | +$1.31M |
2013 Q2
4 quarters
|
|
15
Ametek
AME
$56.9B
| $7.99M | 0.81% |
152,830
+19,975
| +15% | +$1.05M |
2013 Q2
4 quarters
|
|
16
Microsoft
MSFT
$3.94T
| $7.94M | 0.8% |
190,289
+18,571
| +11% | +$752K |
2013 Q2
4 quarters
|
|
17
Autodesk
ADSK
$50.7B
| $7.83M | 0.79% |
138,830
+11,425
| +9% | +$579K |
2013 Q2
4 quarters
|
|
18
Cummins
CMI
$73.2B
| $7.76M | 0.79% |
50,320
+8,075
| +19% | +$1.22M |
2013 Q2
4 quarters
|
|
19
LKQ Corp
LKQ
$4.35B
| $7.61M | 0.77% |
284,980
+33,845
| +13% | +$935K |
2013 Q2
4 quarters
|
|
|
RHT
20
DELISTED
Red Hat Inc
RHT
| $7.46M | 0.75% |
134,880
+27,285
| +25% | +$1.39M |
2013 Q2
4 quarters
|
|
21
DELISTED
Nordstrom
JWN
| $7.42M | 0.75% |
109,280
+7,935
| +8% | +$515K |
2013 Q2
4 quarters
|
|
|
AGN
22
DELISTED
Allergan Inc
AGN
| $7.3M | 0.74% |
43,163
+36,863
| +585% | +$5.74M |
2013 Q2
4 quarters
|
|
|
SIVB
23
DELISTED
SVB Financial Group
SIVB
| $7.28M | 0.74% |
62,400
+7,125
| +13% | +$794K |
2013 Q2
4 quarters
|
|
24
DELISTED
Southwestern Energy Company
SWN
| $7.22M | 0.73% |
158,728
+24,810
| +19% | +$1.15M |
2013 Q2
4 quarters
|
|
25
Graco
GGG
$10.8B
| $7.11M | 0.72% |
273,270
+34,800
| +15% | +$859K |
2013 Q2
4 quarters
|
|
Similar funds
SCM
CH
FOAM
HGI
Wilmington Funds Management's Q2 2014 Portfolio in Review
As of Q2 2014, Wilmington Funds Management held 873 positions worth $988M, up 7.4% from $920M the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Wilmington Funds Management deployed $35.7M of net new capital in Q2 2014, opening 103 new positions and adding to 253 existing holdings. Its largest new stake was AstraZeneca: 88,300 shares worth $6.56M.
By sector, the portfolio is most concentrated in Industrials at 16% of assets, down from 16% a quarter earlier, followed by Healthcare and Consumer Discretionary.
On the sell side, the largest reduction was Citrix Systems Inc, an estimated $5.03M trimmed.
- Wilmington Funds Management's largest Q2 2014 buy was AstraZeneca: 88,300 shares worth $6.56M.
- Wilmington Funds Management added most to Allergan Inc in Q2 2014, an estimated $5.74M increase.
- Wilmington Funds Management's biggest Q2 2014 reduction was Citrix Systems Inc, cutting an estimated $5.03M.
- Wilmington Funds Management fully exited Wolfspeed in Q2 2014, selling an estimated $1.9M.
- Wilmington Funds Management's ten largest holdings make up 11% of its $988M portfolio in Q2 2014.
- Wilmington Funds Management opened 103 new positions and closed 127 in Q2 2014.
- Wilmington Funds Management's portfolio value rose 7.4% quarter-over-quarter to $988M.
Based on Wilmington Funds Management's 13F filing for Q2 2014, filed 13 Aug 2014.